Michael Casamento
Analyst · Jakob Cakarnis with Jarden Australia. Your line is now open
Thanks, Ron. Hi, everyone. And turning to Slide 6 and beginning with the flexibles, the business performed very well through the half year as our teams demonstrated impressive focus when it comes to recovering higher input costs and managing operating performance, whilst delivering growth in higher-value priority segments. Reported sales growth of 10% for the half includes recovery of approximately $480 million of higher raw material costs or 10% growth compared with last year. And in the December quarter, recoveries reached almost $1.1 billion on an annualized basis. Consistent with the outcome in the first quarter and as expected, the overall price cost impact in the first half was unfavorable, but remains manageable, given the diversity of materials we buy, the multiple regions in which we consume those materials and the implementation of a broad range of pricing actions. As a result, margins have remained strong at 12.9%, despite higher raw material costs and related pricing recovery. At $480 million through the half, the top line recovery alone had an unfavorable impact on margins of 130 basis points. Excluding this raw material impact, revenue growth of 2% was driven by favorable mix across the business, and reflects our long-term strategy of optimizing performance through the delivery of consistent growth in priority segments, including health care, coffee and pet food. Notwithstanding the dampening effect on volumes that supply chain disruptions had during the period in some categories, including health care and protein products, overall volumes across the business were in line with the first half last year, and we saw low single-digit volume growth in the December quarter. In terms of earnings, adjusted EBIT was up 7% for the half and reflects growth in high-value segments and strong operating cost performance. Turning to the Rigid Packaging business on Slide 7. Reported sales grew by 17% in the half, including 13% related to the pass-through of higher raw material costs. Excluding the raw material recovery, the business delivered year-to-date sales growth of 4% against a strong period of double-digit growth last year, and this included a 3% increase in volumes as well as a 1% price mix benefit. In North America, underlying demand in the beverage business remains strong, and year-to-date volumes were 3% ahead of the same period last year, accelerating to 6% in the December quarter and building on 13% growth delivered in the second quarter last year. Hot fill container volumes were broadly in line with the second quarter last year, notwithstanding we are cycling growth of almost 30% in the prior year. We have seen good volume growth in isotonics as well as iced tea categories, where customer demand for 100% recycled PET bottles has been strong. Specialty container volumes were lower against the prior year, which also benefited from higher volumes in the home and personal care category. And in Latin America, the business delivered double-digit volume growth reflecting strength in Argentina, Mexico and Colombia, and earnings were higher. From an earnings perspective, the business in North America was adversely impacted as we expected, by inefficiencies and higher costs resulting from industry-wide supply chain complexity and disruptions. As Ron mentioned, earnings performance improved as we exited the second quarter, and this was helped by a number of positive trends, including better availability of PET resin and new capacity coming online, which also supported our ability to build some additional inventories ahead of the peak summer season. Although the operating environment is likely to remain dynamic and somewhat complex, we anticipate conditions will continually improve, and earnings for the Rigid Packaging segment are expected to grow in the second half compared with the same period last year. Moving to cash and the balance sheet on Slide 8. First, as a reminder, our cash flow is seasonally weaker in the first half of the fiscal year, and this year, we delivered cash flow within our range of expectations for the half, particularly in light of a higher cost environment. First half cash flow was below last year, and this mainly reflects the timing impact of higher raw material costs on working capital across the business, along with planned inventory increases. We continue to maintain a strong focus on working capital performance, which is even more critical in an inflationary environment and our rolling working capital to sales ratio remains below 8% and in line with last year. As planned, capital expenditure is tracking higher than last year as we have stepped up organic investments in priority segments and geographies. And Amcor's balance sheet remains strong with leverage at 2.9x on a trailing 12-month EBITDA basis, which is where we'd expect to be at this time of the year, given seasonality of cash flows. Cash returns to shareholders in the first half were almost 50% higher than last year and we increased our quarterly dividend per share and repurchased a greater amount of shares. And as Ron mentioned earlier, we now expect to allocate a total of $600 million towards share repurchases in the 2022 fiscal year, which includes the additional $200 million announced today. Taking us to the outlook on Slide 9. The business has delivered a solid result for the half, in line with our expectations, and the outlook for our business remains positive. This enables us to do two things today. First, reaffirm the 2022 guidance we outlined in August and November, where we continue to expect adjusted EPS growth of 7% to 11% on a comparable constant currency basis, which represents an EPS guidance range of approximately $0.79 to $0.81 per share on a reported basis, assuming current exchange rates prevail for the balance of the year. And we continue to expect free cash flow in a range of $1.1 billion to $1.2 billion. Secondly, our positive outlook leaves us well positioned to increase our share repurchase by $200 million in fiscal '22, as previously mentioned. It's important to note the majority of these additional repurchases are expected to take place in the fourth quarter. And due to the limited impact this will have on the weighted average number of shares outstanding in fiscal 2022, there is not expected to be any real benefit to EPS growth until fiscal '23. So with that, I'll hand back to Ron.